# Pandorum Technologies Pvt.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pandorum-technologies-pvt

- Industry: Biotechnology
- Headquarters: Bangalore, India
- Website: www.pandorum.com/
- Total disclosed funding: $27M
- Latest round: Series B (Dec 19, 2025)
- Investors on record: 12

## About

Based in Karnataka, India, and founded in 2011 by CEO Tuhin Bhowmick and Arun Chandru, Pandorum Technologies Pvt. Ltd., a.k.a. Pandorum Technologies operates as a biotechnology company that develops regenerative treatments and tissue engineering for impaired cornea and liver. In December 2025, Pandorum Technologies Pvt. Ltd. raised USD 18 million in series B funding led by Protons Corporate, with participation from Galentic Pharma, Noblevast Advisory, Avinya Ventures, and Burman Family Holdings. 

Pandorum Technologies offers bioengineered solutions for corneal, liver, and lung conditions. The company’s bioengineered cornea addresses various corneal disorders. The mini liver platform replicates the liver’s natural environment to aid in drug discovery and developmental studies. For lung regeneration, Pandorum is developing a cell-free treatment to repair inflammation and fibrosis damage, to improve lung function post-trauma.

The company will use the December 2025 funding to advance clinical development of its exosome-based therapies, scale global manufacturing, and expand operations in the United States, Japan, and the Middle East.

## Funding rounds

- Series B, Dec 19, 2025, $18M — Burman Family Holdings, Avinya Ventures, Galentic Pharma India Pvt. Ltd.
- Series B, Sep 8, 2020, $5.7M — Karnataka Asset Management Company, Kotak Alternate Asset Managers, Capital Trust Ltd, Indian Angel Network, Xeed Ventures, BTB Ventures, BFL Investments & Financial Consultance Pvt Ltd
- Series A, Dec 30, 2017, $3.4M — Karnataka Asset Management Company, 500 Global, Indian Angel Network, Clarion Technologies, Inc., Xeed Ventures, BFL Investments & Financial Consultance Pvt Ltd

## Investors

- Karnataka Asset Management Company (https://capitalatlas.ai/funds/karnataka-asset-management-company) — Series A, Series B
- 500 Global (https://capitalatlas.ai/funds/500-global) — Series A
- Indian Angel Network (https://capitalatlas.ai/funds/indian-angel-network) — Series A, Series B
- Clarion Technologies, Inc. — Series A
- Xeed Ventures (https://capitalatlas.ai/funds/xeed-ventures) — Series A, Series B
- BFL Investments & Financial Consultance Pvt Ltd — Series A, Series B
- Kotak Alternate Asset Managers (https://capitalatlas.ai/funds/kotak-alternate-asset-managers) — Series B
- Capital Trust Ltd — Series B
- BTB Ventures — Series B
- Burman Family Holdings — Series B
- Avinya Ventures (https://capitalatlas.ai/funds/avinya-ventures) — Series B
- Galentic Pharma India Pvt. Ltd. — Series B